HMGB1 and nervous system disorder: Recent studies have shown that SIRT1 activation can reduce the secretion of high-mobility group box 1 (HMGB1) and moderate the subsequent HMGB1/TLR4/MyD88/NF-κB signaling pathway to exert protective and anti-inflammatory effects against neurological disorders (47, 48).